It is gods, I say, who are corrupt, not man, for while they have created his imperfections and so jealously guarded their secrets, the man with all his frailties has gallantly sought to understand and undo Nature's insults.Anonymous
References
Anderson, W. McC., and Dawson, J.: The clinical manifestations of depressive illness with abnormal acetyl methyl carbinol metabolism. J. Ment. Sci. 108: 80, 1962.
—: Verbally retarded depression and sodium metabolism. Brit. J. Psychiat., 109: 225, 1963.
Ashcroft, G. W., and Sharman, D. F.: 5-hydroxyindoles in cerebrospinal fluid. Nature, 186: 1050, 1960.
Baastrup, P. C., and Schou, M.: Lithium as a prophylactic agent against recurrent depressions and manic-depressive psychosis. Arch. Gen. Psychiat., 16: 162, 1967.
Bonting, S. L.; Simon, K. A., and Hawkins, N. M.: Studies on sodium potassium activated adenosine triphosphatase. I. Quantitative distribution in several tissues of cat. Arch. Biochem., 95: 416, 1961.
Brooksbank, B. W. L., and Coppen, A.: Plasma II-hydroxycorticosteroids in affective disorders. Brit. J. Psychiat., 113: 395, 1967.
Brown, D. G.; Hullin, R. P., and Roberts, J. M.: Fluid distribution and the response of depression to ECT and imipramine. Brit. J. Psychiat., 109: 395, 1963.
Bunney, W. E.; Mason, J. W., and Hamburg, D. A.: Correlations between behavioral variables and urinary 17-hydroxycorticosteroids in depressed patients. Psychosom. Med. 27: 299, 1965.
Cade, J. F. L.: A significant elevation of plasma magnesium levels in schizophrenia and depressive states. Med. J. Australia, 1: 195, 1965.
Carlsson, A.: The occurrence, distribution and physiological role of catecholamines in the central nervous system. Pharmacol. Rev., 11: 490, 1959.
—: Functional significance of drug induced changes in brain monoamine levels. Prog. Brain Res. 8: 9, 1964.
Chignell, C. F.; Roddy, P. M., and Titus, E. O.: Effect of adrenal steroids on Na+−K+ dependent adenosine triphosphatase. Life Sci., 4: 559, 1965.
Coppen, A. J.: Abnormality of the blood cerebrospinal fluid barrier of patients suffering from a depressive illness. J. Neurol., Neurosurg., Psychiat., 23: 156, 1960.
—: Mineral metabolism in affective disorders. Brit. J. Psychiat., 111: 1133, 1965.
—: Biochemistry of affective disorders. Brit. J. Psychiat., 113: 1237, 1967.
Coppen, A. J.; Malleson, A., and Shaw, D. M.: Effects of lithium carbonate on electrolyte distribution in man. Lancet 1: 682, 1965.
Coppen, A. J., and Shaw, D. M.: Mineral metabolism in melancholia. Brit. Med. J., 2: 1439, 1963.
Coppen, A. J.; Shaw, D. M.; and Farrell, J. P.: Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet 1: 79, 1963.
Coppen, A. J.; Shaw, D. M.; Herzberg, B., and Maggs, R.: Tryptophan in the treatment of depression. Lancet, 1: 1178, 1967.
Coppen, A. J.; Shaw, D. M.; Malleson, A.; and Costain, R.: Mineral metabolism in mania. Brit. Med. J., 1: 71, 1966.
Coppen, A. J.; Shaw, D. M.; Malleson, A.; Eccleston, E., and Gundy, G.: Tryptamine metabolism in depression. Brit. J. Psychiat., 111: 993, 1965.
Coppen, A. J.; Shaw, D. M.; and Mangoni, A.: Total exchangeable sodium in depressive illness. Brit. Med. J., 2: 295, 1962.
Crammer, J. L.: Water and sodium in two psychotics. Lancet, 1: 1122, 1959.
Crisp, A. H., and Roberts, F. J.: The response of an adrenalectomized patient to ECT. Am. J. Psychiat., 119: 784, 1963.
Dahlström, A., and Fuxe, K.: Evidence for the existence of monoamine containing neurons in the central neurous system. Acta. Physiol. Scand., 62: Suppl. 232, 1964.
Dawson, J., and Bone, A.: The effect of alterations in tissue K+ concentrations on the production of 3-hydroxybutan-2-one by brain slices. J. Neurochem., 10: 537, 1963.
Dawson, J.; Hullin, A. P., and Pool, A.: Varations in the blood levels of acetoin and butane 2: 3-diol in normal individuals and mental patients. J. Ment. Sci., 100: 536, 1954.
Doig, R. H.; Mummery, R. V.; Wills, M. R., and Elkes, A.: Plasma cortisol levels in depression. Brit. J. Psychiat., 112: 1263, 1966.
Epstein, F. H., and Whittam, R.: Mode of inhibition by calcium of cell membrane adenosine triphosphatase activity. Biochem. J., 99: 232, 1966.
Flach, F. F.: Calcium metabolism in states of depression. Brit. J. Psychiat., 110: 588, 1964.
Fotherby, K.; Ashcroft, G. W.; Affleck J. W., and Forrest, A. D.: Studies on sodium transfer and 5-hydroxyindoles in depressive illness. J. Neurol., Neurosurg., Psychiat., 26: 71, 1963.
Fras, I.; Litin, E. M., and Pearson, J. S.: Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am. J. Psychiat., 123: 1553, 1967.
Gellhorn, E.: Prolegomena to a theory of the emotions. Perspect. Biol. Med., 4: 403, 1961.
Gibbons, J. L.: Total body sodium and potassium in depressive illness. Clin. Sci., 19: 133, 1960.
—: Cortisol secretion rates in depression. Arch. Gen. Psychiat., 10: 572, 1964.
—: The secretion rate of corticosterone in depressive illness. J. Psychosom. Res., 10: 263, 1966.
—: Biochemistry of depressive illness. In: Recent Developments in Affective Disorders, A. Symposium. A. Coppen, and A. Walk, editors. Headley Bros., Ltd. Kent, England. 1968.
Gibbons, J. L. and McHugh, P. R.: Plasma cortisol in depressive illness. J. Psychiat. Res., 1: 162, 1962.
Gilbert, G. J., and Glaser, G. H.: On the nervous system integration of water and salt metabolism. Arch. Neurol. and Psychiat., 5: 17, 1961.
Glen, A. I. M., Ongley, G. C., and Robinson, K.: Diminished membrane transport in manic-depressive psychosis and recurrent depression. Lancet, II: 241, 1968.
Goldfarb, C.; Driese, J., and Cole, D.: Psychophysiologic aspects of malignancy. Am. J. Psychiat., 123: 1545, 1967.
Guze, S. B.: The occurrence of psychiatric illness in systemic lupus erythematosus. Am. J. Psychiat., 123: 1562, 1967.
Hamburg, D. A.: Plasma and urinary corticosteroid levels in naturally occurring psychological stresses. Res. Proc. Asso. Nerv. Ment. Dis., 40: 406, 1962.
Hillarp, N. Å.; Fuxe, K., and Dahlström, A.: Demonstration and mapping of central neurons containing dopamine, noradrenaline and 5-hydroxytryptamine and their reactions to psychopharmaca. Pharmacol. Rev., 18: 727 1966.
Hoffman, J. F.: Cation transport and structure of red cell plasma membrane. Circulation, 26: 1202, 1962.
Jenner, F. A.; Gjessing, L. R.; Cox, J. R.; Davies-Jones, A.; Hullin, R. P., and Hanna, S. M.: A manic-depressive with a persistent 48-hour cycle. Brit. J. Psychiat., 113: 895, 1967.
Katz, A. I., and Epstein, F. H.: Role of sodium-potassium activated adenosine triphosphatase in reabsorption of sodium by kidney. J. Clin. Inv., 46: 1999, 1967.
—: Physiologic role of sodium-potassium activated adenosine triphosphatase in the transport of cations across biologic membranes. N. E. J. Med., 278: 253, 1968.
Katz, R. I.; Chase, T. N., and Kopin, I. J.: Evoked release of nor-epinephrine and serotonin from brain slices: Inhibition by lithium. Science, 162: 446, 1968.
Kernan, R. P.: Cell K+. P. 121. Butterworth. London. 1965.
Klerman, G. L.; Schildkraut, J. J.; Hasenbush, L. L.; Greenblatt, M., and Friend, D. G.: Clinical experience with dihydroxy-phenyalanine (dopa) in depression. J. Psychiat. Res., 1: 289, 1963.
Knapp, M. S.; Keane, P. M., and Wright, J. G.: Circadian rhythms of plasma 11-hydroxycorticosteroids in depressive illness, congestive heart failure and Cushing's Syndrome. Brit. Med. J., 2: 27, 1967.
McClure, D. J.: The diurnal variation of plasma cortisol levels in depression. J. Psychosom. Res., 10: 189, 1966.
Moore, F. D.; McMurrey, J. D.; Parker, H. V., and Magnus, I. C.: Body composition, total body water and electrolytes: intravascular and extravascular phase volumes. Metabolism, 5: 447 1956.
Moore, F. D.; Olsen, K. H.; McMurrey, J. D.; Parker, H. V.; Ball, M. R., and Boyden, C. M.: The Body Cell Mass and its Supporting Environment Saunders. Philadelphia. 1963.
Mosher, L. R.; Klerman, G. L., and Greanly, J. F.: A clinical trial of alphamethyldopa in elated states. Am. J. Psychiat., 122: 1185, 1966.
Pitts, F. N., Jr., and McClure, J. N., Jr.: Lactate metabolism in anxiety neurosis. N. E. J. Med., 277: 1329, 1967.
Pletscher, A.; Shore, P. A., and Brodie, B. B.: Serotonin as a mediator of reserpine action in brain. J. Pharmacol., 116: 84, 1956.
Prada, Da. M.; Tranzer, J. P., and Pletscher, A.: Effect of drug and cations on ultrastructure and 5-hydroxytryptamine content of blood platelets. J. Pharmacol. Exp. Therap., 158: 1967.
Robinson, J. D.: Kinetic studies on a brain microsomal adenosine triphosphatase. Evidence suggesting conformational changes. Biochem., 6: 3250, 1967.
Russell, G. F. M.: Body weight and balance of water, sodium, and potassium in depressed patients given electroconvulsive therapy. Clin. Sci., 19: 327, 1960.
Schottstaedt, W. W.; Grace, W. J., and Wolff, H. G.: Life situations, behavior, attitudes, emotions, and renal excretion of fluid and electrolytes-IV. J. Psychosom. Res., 1: 287, 1956.
Shagass, C., and Schwartz, M.: Somatosensory cerebral evoked responses in psychotic depression. Brit. J. Psychiat., 111: 269, 1966.
—: Physiological correlates of psychological disorder. R. Roessler and N. S. Greenfield, editors. University of Wisconsin Press. Madison. 1962.
Shaw, D. M.: Mineral mettabolism, mania and melancholia. Brit. Med. J., 2: 262, 1966.
Shaw, D. M., and Coppen, A. J.: Potassium and water distribution in depression. Brit. J. Psychiat., 112: 269, 1966.
Shaw, D. M.; Eccleston, E. G., and Camps, F. E.: 5-hydroxytryptamine in the hind brain of depressive suicides. Brit. J. Psychiat., 113: 1407, 1967.
Skou, J. C.: Influence of some cations on adenosine triphosphatase from peripheral nerves. Biochem. Biophys. Acta, 23: 394, 1957.
—: Further investigations on Mg++ +Na+ activated adenosine triphosphatase, possibly related to active linked transport of Na+ and K+ across cell membrane. Biochem. Biophys. Acta, 42: 6, 1960.
Spector, S.; Prockop, D.; Shore, P. A., and Brodie, B. B.: Effect of iproniazid on brain levels of norepinephrine and serotonin. Science, 127: 704, 1958.
Stenbäck, A., and Haapanen, E.: Azotemia and psychosis. Acta Psych. Scand. 43: Suppl. 197, 1967.
Ström-Olsen, R., and Weil-Malherbe, H.: Humoral changes in manic-depressive psychosis with particular reference to the excretion of catecholamine in urine. J. Ment. Sci., 104: 696, 1958.
Whatmore, G. B.: Some neurophysiologic differences between schizophrenia and depression. Am. J. Psychiat., 123: 712, 1966.
Whatmore, G. B., and Ellis, R. M., Jr.: Further neurophysiologic aspects of depressed states. An electroencephalographic study. Arch. Gen. Psychiat., 6: 243, 1962.
Whybrow, P. C.; Kane, F. J., and Lipton, M. A.: Regional ileitis and psychiatric disorder. Psychosom. Med., 30: 209, 1968.
Woodbury, D. M.: Relation between the adrenal cortex and the central nervous system. Pharmacol. Rev., 10: 275, 1958.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singh, M.M. A unifying hypothesis on the biochemical basis of affective disorder. Psych Quar 44, 706–724 (1970). https://doi.org/10.1007/BF01563010
Issue Date:
DOI: https://doi.org/10.1007/BF01563010